Window to China
The project will cover major areas of China, focussing on the dominant Han ethnic group but also including nine ethnic minorities with a population of 5 million or more. A major goal is to study transformation from health to disease, environmental impacts, and the interactions between environmental factors and genes, and its influence on people’s […]
The Chinese blood market, with liberalized price control, grew by 16.7 % from 2015 to 2016. It is served by 28 companies which operate about 200 collection stations. There are 11 types of blood products of which human serum albumin is 54 %, human immunoglobulins 24 %. Factor VIII accounted for 6.3 % of blood […]
The National GenBank with headquarters in Shenzhen will eventually integrate other regional centers already established in China. Suzhou Biological Sample Bank (National Bank of Suzhou Library), formerly known as Suzhou City Serum (Gene) Library, was a project of Suzhou Municipal Government started in 2010; its design stems from a 2004 China-Britain chronic disease prospective study. […]
According to QIAN Qijun, director of the Shanghai Cell Therapy Engineering Research Center, China will have at least a 20 companies or institutions to start CAR-T clinical trials soon, as many funds have been or are being flooded into the field of cellular immunotherapy. According to Founder Securities, at present there are more than 20 […]
The Systems and Synthetic Biotechnology Research Team around MA Yanhe at CAS TIB has developed a versatile CRISPR/Cas9 genome editing toolbox for C. glutamicum. Cas9 and gRNA expression cassettes were reconstituted to combat Cas9 toxicity and facilitate effective termination of gRNA transcription. Co-transformation of Cas9 and gRNA expression plasmids was exploited to overcome high-frequency mutation […]
The projects, which run until 2020, are: 1. Biomedical materials research and development and replacement of tissue and tissue remediation 2. Digital clinic equipment research and development 3. Major chronic non-communicable diseases prevention and control 4. Research on Prevention and Control of Reproductive Health and Major Birth Defects 5. Precision Medicine Research Each of the […]
Batteries based on Mg anodes are safe, show high volumetric capacity, and inexpensive, but the lack of compatible electrolytes and suitable cathodes has restricted the development of rechargeable Mg batteries. A group at CAS Qingdao Institute of Bioenergy has developed to this end a new type of organic magnesium borate based electrolyte which was synthesized […]
As the use of biomass energy is moving only slowly, the National Energy Administration and the Ministry of Environmental Protection have jointly started a pilot project on power generation coupling coal-incineration and biomass. Priority for cogeneration is limited to projects on coal-fired agricultural and forestry residues coupled with power generation technology projects, focusing on 13 […]
The group of Qiang WANG at the institute used waste streams from biomass power plants as nutrients for Chlorellac ultivation and found that Chlorella cultures produced 39 % more lipids and exhibited higher growth rates. The cultures reduced the NOx present in the flue gas and sequestered CO2, with a NOx reduction (DeNOx) efficiency of ∼100%, and […]
The CAS Innovation Cooperation Center (Bangkok) will bethe first overseas organization promoting global science, technology and innovation. The center will encourage Chinese innovative enterprises to come to Southeast Asia to build an innovative China-ASEAN community. Princess Maha Chakri Sirindhorn has visited CAS for many times to help the two countries cooperate on various fields such […]